-
12-13 March 2024, RAI Congress Centre, Amsterdam
World leading healthcare evidence, pricing and access congress
8
Tracks
1500+
Delegates
300+
Speakers
120+
Exhibitors
What is World Evidence, Pricing and Access Congress Europe?
Conference
Covering market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes research in healthcare
Exhibition
90+ leading solution producers to meet your needs across evidence generation, market access, pricing, rare diseases and more to enable operational excellence
Networking
Networking is at the heart of the World Evidence Pricing and Access Congress. Our congress allows you to connect directly with key decision makers across 2 days of built in one to one networking
Topics
Evidence
Patient centred outcomes
Evidence generation
Real world evidence
Market Access
Early access schemes
Access in LMICs
Investment strategies
Pricing
Reimbursement
Value based healthcare
Pricing from start-up perspectives
Procurement practices
Rare Diseases
Value based therapies for rare diseases
Payer engagement
Launching products
Patient journey in accessing new treatments
Advanced Therapies
Pricing approaches for gene therapies
Early pipeline development
Managed entry agreements
Digital Transformation
Data analytics
Digital therapeutics
Use of data for HTAs
HTA
New EU HTA regulations
Gaps in evidence
Healthcare decision making
Risk sharing agreements
Health Economics and Outcomes Research
Clinical outcomes assessments
Innovating economic processes
Modelling health inequalities
Broadening the definition of value
Key communities and industries come together
Our incredible line-up for 2024
Over 210 speakers
Ana Filipa AlexandreVice President, Head of Pricing and Market AccessSanten
Amer Al-TaieSenior Director, Value & Evidence Team LeadPfizer
Alexander BastianVice President, Value & Market AccessA.M. Pharma
Chris BidadGlobal Head, Access Strategy and Payer PolicyAstraZeneca
Thomas BolsHead of Government Affairs and Patient Advocacy, EMEAPTC Therapeutics
Laurent CarterSenior Vice President, Head of Global PricingBristol-Myers Squibb
Sandro CesaroHead of Europe Market Access & PricingAstrazeneca
Mata CharokopouSenior Director, Global Head of Access, Pricing & ValueUCB
Alina CharterVP Market Access, Pricing and PolicyAlnylam
Sally ChungVice President, Head of Market Access & Pricing EuropeGSK
Matt CullenVice President, Value, Access & PolicyLexicon Pharmaceuticals, Inc.
Marcus DahlmanHead of Market Access EuropeHansa Biopharma
Michele de GuisePresident and Chief Executive OfficerINESSS
Riad DiraniVice President, Global HEOR, Medical Operations & ExcellenceTeva Pharmaceuticals
Patricia DorlingHead, Global HEOR and Real World EvidenceChiesi Group
Dilesh DoshiVice President, Global Health Economics and Outcomes ResearchAcadia Pharmaceuticals Inc.
Gina EwyVP, Head of Global Market AccessHansa Biopharma
Stefaan FiersHead of Corporate Communication, Public Affairs & Patient Advocacy, BelgiumTakeda
Lora FleifelDirector, Market Access Operations, Oncology EuropeMerck
Benjamin GannonVice President, InternationalGuardant Health
Ramiro GilardinoSenior Director, Global HTA & Access Policy LeadMSD
Christoph GlaetzerChief Global Value and Access OfficerJanssen
Thomas GrubSenior Expert, Global Pricing and Market Accessmedac GmbH
Marlene GyldmarkVice President, Global Head, HEOR & EpidemiologyIdorsia Pharmaceuticals
Gunter HarmsSenior Director, Patient Access, Germany, Austria, Switzerlandnovartis gene therapies
Birgit HolzGlobal Head, Contracting InnovationSanofi
Kirsty HoyleChief Executive OfficerMetabolic Support UK
Jayasree IyerChief Executive OfficerAccess to Medicine Foundation
Saira JanVice-President & Chief Pharmacy OfficerBlue Cross Blue Shield of New Jersey
Elizabeth KinterVice President, Head of Evidence, Value and AccessVir Biotechnology
Marianne LaouriExecutive Director, Value Demonstration, Specialty Products & Quality of CareBoehringer Ingelheim
Agathe Le LayVice President, Head of Global Value Evidence & Patient Insights, Medical AffairsH. Lundbeck A/S
Katja LundellSenior Director, Global Head of Pricing, Access and Communicationstheramex
Elena LunguManager of Policy Development, Patented Medicine Prices Review BoardGovernment of Canada
Charles MakinGlobal Head, Health Economics and Outcomes Research, HTA & Real-World EvidenceBiogen
Chris MancillSenior Vice President, Head, Global Market Access, Pricing, and Value DemonstrationBristol Myers Squibb
Silvy MardiguianSenior Director, Head of HEOR, Europe & New MarketsBeigene
Sean McElligottExecutive Director, Head, US Health Economics Outcomes ResearchNovartis
Erin MistryExecutive Vice President, Chief Commercial OfficerCorMedix Inc
Tal MorginstinDirector, HTA divisionMinistry of Health, Israel
Claudia NeuberHead of Global Pricing, OncologyAstraZeneca
Enkeleida Nikai-FitzgeraldVice President, Head of Global Real-World Evidence, GenMedSANOFI
Eric NoehrenbergGlobal Vice President, Market Access and Government AffairsCORCYM
Andrew OlayeExecutive Director, Head of Market Access and Partnership EMEAOrchard Therapeutics Ltd
Lucinda OrsiniVice President, Value and Outcomes ResearchCOMPASS Pathways
Donal O'SullivanVice President, Head of Pricing & TendersCSL Vifor
Ipek Ozer-StillmanVice President, Global Head, Health EconomicsTakeda
Marco RaulandVice President, Global Head of GVAP Strategic Planning & Data Science, Global Evidence Demonstration, Market Access and PricingMerck Group
Rogerio RibeiroSenior Vice President, Head of Global Commercial, Vaccines Business UnitTakeda
Pernille StormVice President, Global Pricing and Market AccessLundbeck
Durhane Wong-RiegerPresident, Chief Executive Officer & ChairCanadian Organisation for Rare Diseases & Rare Diseases International
Proud to announce our 2024 sponsors and exhibitors
Title Sponsor
Diamond
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Remaining marketing opportunities for world class solution providers are selling fast.
Contact: David.Boore@terrapinn.com
"Good content and useful contacts."
- Pfizer
"Very relevant topics across different tracks, which gives opportunity for many presenters to share insights, experience and expertise."
- Ipsos Market Access
"Great opportunity to network with pricing and market access professionals"
- Boehringer Ingelheim International GmbH
"Excellent conference with many market access and health policy topics"
- PTC Therapeutics
Join Us In Amsterdam | 12 - 13 March 2024
Get Involved
Sponsorship & Exhibition Sales
David Boore
david.boore@terrapinn.com
+44 20 8164 3052
Conference Production
George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940
Marketing Opportunities
Diana Cobzac
diana.cobzac@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events